antiretroviral medications
Showing 1 - 25 of 8,821
Evaluate the Relationship Between HIV Medications and Coronary Atherosclerosis Trial in Fort Pierce
Completed
- Evaluate the Relationship Between HIV Medications and Coronary Atherosclerosis
-
Fort Pierce, Florida
- +1 more
Apr 19, 2022
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence
Recruiting
- HIV-positive Individuals
- MyTPill, a digital pill
-
Miami, FloridaUniversity of Miami
Dec 1, 2022
Adult, HIV Trial in Surabaya (Adherence toolkit)
Not yet recruiting
- Adult
- HIV Infections
- Adherence toolkit
-
Surabaya, IndonesiaHIV clinics
Aug 10, 2023
HIV Trial in Australia (emtricitabine/tenofovir disoproxil fumarate)
Completed
- HIV
- emtricitabine/tenofovir disoproxil fumarate
-
Camperdown, New South Wales, Australia
- +4 more
Nov 28, 2019
ART Toxicities Study in HIV Uninfected Children Born to HIV
Recruiting
- Antiretroviral Toxicity
-
Birmingham, Alabama
- +21 more
Aug 26, 2022
HIV, Pregnancy Related Trial in Chapel Hill (Doravirine)
Recruiting
- HIV Infections
- Pregnancy Related
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Aug 10, 2022
Abacavir and Lamivudine Anabolites
Completed
- HIV-1-infection
- Blood collection
- +3 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 5, 2023
COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)
Recruiting
- COVID-19
- Hospitalized COVID-19 Patients
- Lopinavir / Ritonavir
- +3 more
-
Zgharta, North, Lebanon
- +1 more
Jun 28, 2023
HIV Trial in Baltimore (Enfuvirtide)
Completed
- HIV
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center
Nov 22, 2021
Adherence Trial in Chicago, Boston, Providence (Positive STEPS)
Active, not recruiting
- Adherence
- Positive STEPS
-
Los Angeles, California
- +3 more
Nov 3, 2022
IMPAACT P1080: Psychiatric and Antiretroviral Medication
Completed
- ADHD
- HIV
-
Birmingham, Alabama
- +21 more
Jul 30, 2021
Medication Adherence Trial in United States (MESA)
Completed
- Medication Adherence
- MESA
-
Los Angeles, California
- +6 more
Aug 18, 2022
HIV/AIDS Trial in Los Angeles (Rise - Treatment Education)
Completed
- HIV/AIDS
- Rise - Treatment Education
-
Los Angeles, CaliforniaAIDS Project Los Angeles
Dec 21, 2022
HIV, Antiretroviral Therapy Trial in New York (Heart to Heart)
Completed
- HIV
- Antiretroviral Therapy
- Heart to Heart
-
New York, New YorkNew York University College of Nursing
Oct 31, 2022
HIV I Infection Trial in Storrs, Atlanta (Uniform Standard of Care Counseling, Behavioral Self-Regulation Skills Counseling,
Recruiting
- HIV I Infection
- Uniform Standard of Care Counseling
- +2 more
-
Storrs, Connecticut
- +1 more
Oct 28, 2021
HIV Trial run by the National Cancer Institute (NCI) (Acute Treatment Interruption)
Recruiting
- HIV
- Acute Treatment Interruption
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 11, 2023
Preparing for Pharmacy-based Delivery of Long-acting Injectable
Recruiting
- Hiv
-
Auburn, Alabama
- +3 more
Jun 10, 2022
HIV Trial in El Dorado Hills (HiDO medication adherence platform, Automated Medication Platform with Video Observation, Time on
Enrolling by invitation
- HIV Infections
- HiDO medication adherence platform
- +2 more
-
El Dorado Hills, CaliforniaHiDO Technologies Inc.
Jul 7, 2022
Bictegravir in the Elderly Living With HIV (BICEP)
Active, not recruiting
- HIV-1-infection
- Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
-
Buffalo, New YorkEvergreen Health
Oct 28, 2022
HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)
Active, not recruiting
- HIV-1-infection
- Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
-
Antwerp, Belgium
- +28 more
May 23, 2022
HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)
Recruiting
- HIV Infections
- +2 more
- Letermovir 240 MG Oral Tablet
- +2 more
-
Birmingham, Alabama
- +18 more
Jun 20, 2022